We also performed this analysis in breast cancer MDA-MB-231 cells where the surface expression of Orai1 was not significantly altered by treatment with tunicamycin, which supports the lack of effect of tunicamycin on SOCE in these cells (Figure S1). The gene discussed is ORAI1; the disease is breast cancer.